Tracking of single virus: Dual fluorescent labeling of pseudorabies virus for observing entry and replication in the

Mingzhi Li1, Li Pan1, Caoyuan Ma1

  • 1State Key Laboratory for Animal Disease Control and Prevention Harbin Veterinary Research Institute, CAAS 678 Haping Road, Harbin, Heilongjiang 150069, China.

PubMed

Insights

This study introduces a dual-fluorescence Pseudorabies virus (PRV) for tracking viral replication. The new tool reveals PRV entry pathways and genome replication, aiding in understanding herpesvirus infection.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Pseudorabies virus (PRV), a neurotropic herpesvirus, presents challenges in tracking its replication, particularly the nascent viral genome within host cells.
  • Understanding PRV's life cycle is crucial for developing effective antiviral strategies.

Purpose of the Study:

  • To develop a novel dual-fluorescence-labeled PRV (rPRV-Anchor3-mCherry) for visualizing viral genome and envelope protein dynamics.
  • To investigate PRV entry mechanisms and replication processes in host cells.

Main Methods:

  • Development of a dual-fluorescence-labeled PRV (rPRV-Anchor3-mCherry) using ANCHOR DNA labeling and mCherry.
  • Single-virus tracking, 3D live-cell imaging, and electron microscopy.
  • CRISPR-Cas9 gene editing to target UL9 and UL54 genes.

Main Results:

  • PRV invasion of Neuro-2a cells occurs through both endocytosis and plasma membrane fusion.
  • Parental and progeny viral genomes are visible in the nucleus during replication, with nucleocapsids appearing more specifically than with traditional labeling.
  • Extensive progeny viral particle production in the nucleus leads to nuclear membrane breakdown.
  • Simultaneous targeting of UL9 and UL54 genes completely inhibits PRV replication.

Conclusions:

  • The rPRV-Anchor3-mCherry system provides a powerful tool for studying multiple stages of the PRV life cycle.
  • Visualizing PRV genome replication and particle production offers new insights into herpesvirus pathogenesis.
  • CRISPR-Cas9 targeting of specific genes presents a potential therapeutic approach for PRV infections.